Trademark Overview
On Wednesday, December 4, 2024, a trademark application was filed for TRUVESIC with the United States Patent and Trademark Office. The USPTO has given the TRUVESIC trademark a serial number of 98884796. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, December 4, 2024. This trademark is owned by CG Oncology, Inc.. The TRUVESIC trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical products for the treatment of cancer, pharmaceutical preparations and biological preparations for the treatment of cancer and immunological disorders; Biopharmaceuticals for the treatment of cancer, namely, antibodies, non-antibody proteins, blood and blood components, stem cells, hormones, blood factors, tumor necrosis factors; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing